Tushar Sharma, MD

Articles by Tushar Sharma, MD

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

ByRohit Chaudhary, MIS,Thomas Kingsley, MD,Sauradeep Sarkar, MD,Joseph Carrington, DO,Galo M. Sanchez Palacios, MD,Tushar Sharma, MD,Jalaj Garg, MD,Rahul Chaudhary, MD, MBA

November 10th 2020

The authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.

Six Sigma Approach to Reduce Door-to-Balloon Time for Patients With STEMI

ByTushar Sharma, MD,Rohit Chaudhary, MIS,Jalaj Garg, MD,Ashok Kondur, MD,Divyanshu Mohananey, MD,Rahul Chaudhary, MD

May 5th 2020

Specific measures using a Six Sigma approach led to sustained reduction of door-to-balloon times among patients with ST-segment elevation myocardial infarction (STEMI) in a community setting.

Latest Updated Articles

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting
November 10th 2020
Six Sigma Approach to Reduce Door-to-Balloon Time for Patients With STEMI
May 5th 2020

Tushar Sharma, MD

Articles by Tushar Sharma, MD

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

Six Sigma Approach to Reduce Door-to-Balloon Time for Patients With STEMI

Latest Updated Articles

Trending on AJMC

Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD

Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

emtelligent Turns Unstructured Clinical Data Into Actionable Insights

Real-World Data Show MASH Progresses Faster Than Trials Suggest

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Tushar Sharma, MD

Articles by Tushar Sharma, MD

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

Six Sigma Approach to Reduce Door-to-Balloon Time for Patients With STEMI

Latest Updated Articles

Trending on AJMC

Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD

Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure

emtelligent Turns Unstructured Clinical Data Into Actionable Insights

Real-World Data Show MASH Progresses Faster Than Trials Suggest